51 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

2183

Linical
JP¥398.000.5%-51.7%JP¥9.0bn/aPE26.6xE17.3%4.0%

4528

Ono Pharmaceutical
JP¥2,115.00-2.0%-23.6%JP¥993.3bJP¥2,336.36PE7.8xE-4.7%3.8%

915

Shandong Wit Dyne HealthLtd
CN¥31.50-4.5%-11.0%CN¥7.4bn/aPE12.5xE14.1%6.3%

661

Changchun High-Tech Industry (Group)
CN¥101.41-3.6%-26.6%CN¥40.8bCN¥195.35PE9xE12.4%4.4%

CPCI

Kahira Pharmaceuticals & Chemical Industries
ج.م66.080%55.0%ج.م986.9mn/aPE8.4xn/a7.6%

NOVN

Novartis
CHF93.92-0.8%3.8%CHF191.6bCHF97.55PE23.8xE10.2%3.4%

600285

Henan Lingrui Pharmaceutical
CN¥24.90-0.6%63.8%CN¥14.0bCN¥30.50PE22.9xE15.5%3.2%

513

Livzon Pharmaceutical Group
CN¥39.480.3%1.8%CN¥32.3bCN¥41.14PE18.4xE9.9%3.4%

SAN

Sanofi
€86.82-2.8%-11.4%€108.5b€108.19PE23.9xE17.0%4.3%

ROG

Roche Holding
CHF249.802.6%-8.8%CHF202.0bCHF278.05PE17.3xE8.5%3.8%

4552

JCR Pharmaceuticals
JP¥583.001.4%-55.6%JP¥72.8bJP¥851.43PE13.2xE4.9%3.4%

4516

Nippon Shinyaku
JP¥3,138.00-0.9%-51.2%JP¥211.4bJP¥3,964.29PE8.2xE-2.1%4.0%

SQURPHARMA

Square Pharmaceuticals
৳204.702.9%-2.4%৳181.5b৳328.00PE9xE12.2%5.1%

1666

Tong Ren Tang Technologies
HK$5.36-0.7%-28.1%HK$6.9bHK$6.55PE10.8xE4.5%3.6%

4105

TTY Biopharm
NT$76.300.5%0.1%NT$19.0bNT$78.00PE16.2xn/a4.6%

3705

YungShin Global Holding
NT$54.000.7%25.3%NT$14.4bn/aPE15.6xn/a4.3%

600479

ZhuZhou QianJin PharmaceuticalLtd
CN¥10.43-6.0%-11.3%CN¥4.4bn/aPE13.7xn/a3.4%

TSPC

Tempo Scan Pacific
Rp1,965.00-1.0%14.2%Rp8.9tn/aPE8.7xn/a7.6%

239

Pak Fah Yeow International
HK$2.502.0%62.3%HK$779.1mn/aPE7.4xn/a8.2%

BXPHARMA

Beximco Pharmaceuticals
৳104.202.2%-28.7%৳46.5b৳177.50PE8.7xE15.6%3.4%

603676

Tibet Weixinkang Medicine
CN¥8.46-3.0%-34.5%CN¥3.7bn/aPE14.8xn/a3.4%

VLS

Vita Life Sciences
AU$2.373.9%32.8%AU$133.5mn/aPE14.7xn/a3.8%

KRKG

Krka d. d
€140.002.6%21.2%€4.4b€131.22PE13.3xE7.0%5.4%

MEGA

Mega Lifesciences
฿36.50-3.9%-5.2%฿31.8b฿48.88PE15.8xE10.9%4.4%
Page 1 of 3
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.